(Q54391141)

English

Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Prognostic roles of human equilibrative transporter 1 (hENT-1) and ribonucleoside reductase subunit M1 (RRM1) in resected pancreatic cancer. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

author name string

Richard Kim

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Ann Tan

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Kevin K Lai

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

John Jiang

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Yixen Wang

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Lisa A Rybicki

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Xiulu Liu

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

language of work or name

0 references

publication date

24 January 2011

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

117

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

14

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

3126-3134

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

Pancreaticoduodenectomy for cancer of the head of the pancreas. 201 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Survival after pancreatoduodenectomy. 118 consecutive resections without an operative mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Adenoviral-mediated overexpression of human equilibrative nucleoside transporter 1 (hENT1) enhances gemcitabine response in human pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

The absence of human equilibrative nucleoside transporter 1 is associated with reduced survival in patients with gemcitabine-treated pancreas adenocarcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Transcription analysis of human equilibrative nucleoside transporter-1 predicts survival in pancreas cancer patients treated with gemcitabine.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Human equilibrative nucleoside transporter 1 levels predict response to gemcitabine in patients with pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Ribonucleotide reductase: regulation, regulation, regulation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

From RNA to DNA, why so many ribonucleotide reductases?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Development of a clinically feasible molecular assay to predict recurrence of stage II colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Discovery of novel tumor markers of pancreatic cancer using global gene expression technology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25883

21 January 2018

Identifiers

10.1002/CNCR.25883

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/21264835

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54391141&oldid=1047892348"